-
Avenacy launches 2 new generics
Avenacy is offering two new products, Fosaprepitant for Injection, which is the generic of Emend, and Fulvestrant Injection, which is the generic of Foslodex. -
DSN Industry Issues Summit: 2024 shopper outlook
Deborah Weinswig, founder and CEO of Coresight Research, provided an in-depth look at the consumer of 2024.